ascopubs.org

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world ...

PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp. This is an ...
ascopubs.org

CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous ...

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: Results from a global multi-site chart review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
The New England Journal of Medicine

Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...
unr.edu

Ph.D. in Epidemiology

The Ph.D. in Epidemiology emphasizes the expertise necessary for a research career in epidemiology. Application deadline: The priority deadline is February 1, with a final deadline of June 1. The Ph.D ...
National Academies of Sciences%2c Engineering%2c and Medicine

Epidemiologic Study on the Health of Veterans Who Served at Fort McClellan, 1979-1999

An ad hoc consensus committee of the National Academies of Sciences, Engineering, and Medicine will conduct an epidemiologic study of the health of veterans who served at Fort McClellan, Alabama, from ...